Bay 55-9837 TFA

Tax included
Bay 55-9837 TFA is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 TFA may be a useful therapy for the research of type 2 diabetes.
MedChemExpress 
HY-P1160A

Data sheet

Size
Multiple sizes
Reactivity
GCGR
Application
Metabolism-sugar/lipid metabolism